Filing summary
Entity mismatch: The supplied filing is for OmniLit Acquisition Corp., not Syntec Optics Holdings, Inc. It is a blank-check company filing and does not report Syntec’s operating results.
Business context and period
Form 10-Q for the quarter ended September 30, 2021. OmniLit was formed to pursue a business combination and had not commenced operations by quarter-end. The financial statements cover the pre-IPO period; the filing reports no operating revenue.
Financial position and results
- At September 30, cash was $528,900; total assets were $711,995, including $183,095 in deferred offering costs.
- Current liabilities were $686,995, including $300,000 due under a related-party note and $363,995 of related-party advances. Working capital deficit was $158,095, excluding deferred offering costs.
- The statements show no general and administrative expense or net loss for the reported periods. No margins or operating cash flow are reported; financing activities provided $528,900 from inception through September 30.
- No long-term debt or off-balance-sheet arrangements were reported. The related-party note and advances were repaid on November 24, 2021, according to the filing.
Changes and subsequent events
No comparable prior-year operating period is presented. After quarter-end, OmniLit completed its IPO on November 12, 2021: 14,375,000 units at $10 each, raising $143.75 million gross, and raised a further $6.92 million from a private placement of warrants. It placed $146.625 million in a trust account. IPO and placement transaction costs were $8.22 million. These post-quarter transactions were not reflected in the September 30 balance sheet.
Outlook, risks, and unusual items
- Management intended to use trust funds principally to complete a business combination. The company had 15 months from the IPO closing to complete one, with up to two three-month extensions under specified conditions; otherwise, public shares would be redeemed and the company liquidated.
- Management said it expected sufficient working capital and borrowing capacity through the earlier of a business combination or one year from the filing, but noted that additional financing might be needed if costs exceed estimates or redemptions are significant.
- The filing says COVID-19 could adversely affect the company or its search for a target, but the effect was not determinable. Completion of a business combination was not assured.
- The Sponsor’s trust-account indemnity may not be collectible: the company had not verified the Sponsor’s ability to pay and believed its assets consisted only of company securities.
- Management reported effective disclosure controls and no material change in internal control during the quarter. No legal proceedings were reported.
Investor facts to verify
- Confirm the intended issuer: this filing is OmniLit Acquisition Corp.’s, not Syntec Optics Holdings, Inc.’s.
- Verify the IPO, private placement, trust funding, transaction costs, and repayment of related-party balances in subsequent filings.
- Track the business-combination deadline, any extension funding, redemptions, and the resulting cash available to a combined company.
- Assess sponsor indemnity capacity and potential additional financing or dilution, including warrant terms.